- Home
- NG vs PLXS Comparison
NG vs PLXS Comparison
Compare NG & PLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NG | PLXS |
|---|---|---|
| Founded | 1984 | 1979 |
| Country | Canada | United States |
| Employees | N/A | 20000 |
| Industry | Precious Metals | Electrical Products |
| Sector | Basic Materials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 5.3B |
| IPO Year | 2002 | 1995 |
Fundamental Metrics
Financial Performance| Metric | NG | PLXS |
|---|---|---|
| Price | $11.39 | $185.96 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | $10.83 | ★ $194.00 |
| AVG Volume (30 Days) | ★ 3.6M | 285.3K |
| Earning Date | 04-24-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 56.11 |
| EPS | N/A | ★ 1.51 |
| Revenue | ★ N/A | N/A |
| Revenue This Year | N/A | $14.26 |
| Revenue Next Year | N/A | $8.22 |
| P/E Ratio | ★ N/A | $123.31 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.26 | $103.43 |
| 52 Week High | $14.40 | $211.84 |
Technical Indicators
Market Signals| Indicator | NG | PLXS |
|---|---|---|
| Relative Strength Index (RSI) | 50.08 | 40.90 |
| Support Level | $9.13 | $132.33 |
| Resistance Level | $12.00 | $186.47 |
| Average True Range (ATR) | 0.84 | 8.56 |
| MACD | -0.04 | -2.87 |
| Stochastic Oscillator | 27.02 | 13.18 |
Price Performance
Historical ComparisonAbout NG Novagold Resources Inc.
Novagold Resources Inc operates in the gold mining industry, focused on advancing the Donlin Gold project in Alaska. The Donlin Gold project is held by Donlin Gold LLC (Donlin Gold), a limited liability company owned equally by wholly owned subsidiaries of NOVAGOLD and Barrick Gold Corporation (Barrick). The company includes exploration and development activities of gold and other precious metals.
About PLXS Plexus Corp.
Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.